Seattle Genetics, Inc. (NASDAQ:SGEN) announced that management will present at the Cowen and Company 35th Annual Health Care Conference on Tuesday, March 3, 8:40 a.m. Eastern Time, Boston. On Friday shares of Seattle Genetics Inc. (NASDAQ:SGEN) closed at $36.25. Company’s sales growth for last 5 years was 40.70% and EPS growth for next 5 years is recorded as 25.10%.
Scorpio Bulkers Inc. (NYSE: SALT) announced that it plans to issue its fourth quarter 2014 earnings press release before the market open on Wednesday, March 4, 2015 and host a conference call on the same day. Scorpio Bulkers Inc. (NYSE:SALT) in last trading activity advanced 5.37% to close at $2.55. Company weekly performance is 13.84% while its quarterly performance stands at -24.78%. Scorpio Bulkers Inc. (NYSE:SALT) is -75.31% away from its 52 week high.
Harmonic Inc. (NASDAQ:HLIT) announced that Carolyn Aver, Harmonic’s CFO, and Peter Alexander, Harmonic’s CMO will present at Pacific Crest’s 10th Annual Emerging Technology Summit at the Park Central Hotel in San Francisco on Tuesday, March 3, 2015 at approximately 4:00 p.m. (Pacific). On last trading day Harmonic Inc. (NASDAQ:HLIT) decreased -0.64% to close at $7.81. Its volatility for the week is 2.28% while volatility for the month is 2.63%. HLIT’s sales growth for past 5 years was 6.30% and its EPS growth for past 5 years was -14.90%. Harmonic Inc. (NASDAQ:HLIT) monthly performance is 10.94%.
Sage Therapeutics, Inc. (NASDAQ:SAGE) reported Net loss was $12.4 million for the fourth quarter and $33.8 million for the year ended December 31, 2014, compared to net loss of $5.7 million and $18.3 million for the comparable periods of 2013. Sage Therapeutics, Inc. (NASDAQ:SAGE) has 0.30% insider ownership while its institutional ownership stands at 94.90%. In last trading activity company’s stock closed at $43.45.
On 20 February, ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) confirmed that it has received notice of nomination by Sarissa Capital Management LP of two director candidates for election at the 2015 Annual Meeting. On last trading day Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) moved down -0.49% to close at $8.13. Its volatility for the week is 5.12% while volatility for the month is 4.79%. ARIA’s sales growth for past 5 years was 45.10% and its EPS growth for past 5 years was -7.90%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) monthly performance is 24.12%.